536 related articles for article (PubMed ID: 28030829)
21. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
22. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
[TBL] [Abstract][Full Text] [Related]
23. MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt.
Yang W; Yang Y; Xia L; Yang Y; Wang F; Song M; Chen X; Liu J; Song Y; Zhao Y; Yang C
Cell Physiol Biochem; 2016; 38(6):2366-74. PubMed ID: 27230035
[TBL] [Abstract][Full Text] [Related]
24. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis.
Mao X; Xu J; Xiao M; Liang C; Hua J; Liu J; Wang W; Yu X; Meng Q; Shi S
Redox Biol; 2024 Jul; 73():103200. PubMed ID: 38781729
[TBL] [Abstract][Full Text] [Related]
25. ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126.
Zhang J; Chen C; Geng Q; Li H; Wu M; Chan B; Wang S; Sheng W
J Cell Physiol; 2024 Jun; 239(6):e31259. PubMed ID: 38515383
[TBL] [Abstract][Full Text] [Related]
26. N
Tian J; Zhu Y; Rao M; Cai Y; Lu Z; Zou D; Peng X; Ying P; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Gut; 2020 Dec; 69(12):2180-2192. PubMed ID: 32312789
[TBL] [Abstract][Full Text] [Related]
27. Modulation of pancreatic tumor potential by overexpression of protein kinase C β1.
Cirigliano SM; Mauro LV; Grossoni VC; Colombo LL; Diament MJ; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LI; Urtreger AJ
Pancreas; 2013 Oct; 42(7):1060-9. PubMed ID: 23695799
[TBL] [Abstract][Full Text] [Related]
28. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
[TBL] [Abstract][Full Text] [Related]
29. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
Li X; Xu H; Yi J; Dong C; Zhang H; Wang Z; Miao L; Zhou W
J Cell Mol Med; 2021 May; 25(10):4671-4683. PubMed ID: 33811437
[TBL] [Abstract][Full Text] [Related]
30. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.
Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW
Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849
[TBL] [Abstract][Full Text] [Related]
31. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
32. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
33. Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.
Karamitopoulou E; Pallante P; Zlobec I; Tornillo L; Carafa V; Schaffner T; Borner M; Diamantis I; Esposito F; Brunner T; Zimmermann A; Federico A; Terracciano L; Fusco A
Eur J Cancer; 2010 May; 46(8):1438-44. PubMed ID: 20185297
[TBL] [Abstract][Full Text] [Related]
34. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
[TBL] [Abstract][Full Text] [Related]
35. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
36. Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer.
Gao F; Huang W; Zhang Y; Tang S; Zheng L; Ma F; Wang Y; Tang H; Li X
Oncotarget; 2015 Nov; 6(36):38667-80. PubMed ID: 26452029
[TBL] [Abstract][Full Text] [Related]
37. miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway.
Song H; Zhang Y; Liu N; Wan C; Zhang D; Zhao S; Kong Y; Yuan L
J Physiol Biochem; 2016 Jun; 72(2):201-11. PubMed ID: 26893028
[TBL] [Abstract][Full Text] [Related]
38. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
[TBL] [Abstract][Full Text] [Related]
39. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.
Yu T; Wu Y; Hu Q; Zhang J; Nie E; Wu W; Wang X; Wang Y; Liu N
Oncotarget; 2017 Apr; 8(16):26637-26647. PubMed ID: 28460453
[TBL] [Abstract][Full Text] [Related]
40. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
